| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vra5g1001 | ATGTCCAAAGTGCCCCTCTTTATTTCATTTCATTTCTTTCTGTTATTCAGCGTCGCTGTACCCTCTCGGGTAATTTCAGAAACTGAACAAACAATTTTACTCACTCTCAAACGTGAACTGGGAGACCCACCGTCGCTCCGATCATGGAAACCGTCTCCTTCTGCGCCGTGCGAGTGGGCGGAGATTGGATGCAGCAGCGGCGGCGCCGTCACGAAGCTAGTCCTCTCCAGCAAAGGCATCACCACCACCAAGAGCCTTCCTTCCACAATCTGCAACCTCAAACACCTACTTGAGCTTAACCTCTTCAACAACTCCATTTCCGGCGAGTTTCCGACAACCTTGTACGAATGCTCCAACCTCCGGTACCTCAACCTGTCGCAGAACTACCTCGCTGGAGCGATCCCCGCCGACGTGGACCGCCTCAAAACCCTCACTTTCCTGGACCTCAGCGCCAACTCCTTCTCCGGAGAGATCCCGGCCGCGATTGGGAACCTGTCAGAACTGCAAACGCTGTATCTGTCCGCAAACAACTTCGAGGGAACTGTCCCCAGGGAAATCGGAAACTTGTTGAACCTCGAATTTTTGGGTTTGGCTTATAATCTCAAACTCGCGCCGTGGGAGTTCCCGTTGGAGTTTAGGAAATTAAAAAATTTGAGGTCTATGTATATGCCGCAGTGTAACTTGATCGGAGAGATTCCAGAATATTTCGGGGATATTTTCACGAACCTCGAACGGTTGGATTTGGGGAAGAACAAGTTATCAGGGAGCATTCCGAGGAATTTGTTCTCGCTGAGGAAGTTGAGGTTCTTGTACCTGTTCAGTAACAGATTGTCGGGTGTGATTCCTAGTACTACGATGCAGTGTTTGGAATTAATCGAGCTTGATTTCGCGAAGAATAATTTGACGGGTTCCATACCCCCAGAGTTTGGAAAGTTAAAGAACTTGAGTACCTTGCACTTGTACGAAAATCACTTGGTCGGTGAGATTCCCGTAAGTTTAAGCCAAATTCCTAGTCTCGTCTATTTCAGGGTTTTCAGCAATAACTTGAGTGGAACACTGCCTCCAGAACTAGGCTTGCATTCCAAGCTTACAGTGTTTGAGGTTTCTGAGAACCAGCTCAGTGGTGGGTTGCCGGAACATTTATGTGCAGGTGGTGCCCTTATTGGTGTGGTTGCATTTTCCAACAATTTTAGTGGGGTTTTGCCTGAGTGGATTGGGAATTGTCCTTCTCTAGCCACGGTTCAGCTTTATAATAACAAGTTTTCGGGTGAGGTTCCTTTGGGTTTGTGGACTATGAATAACCTTTCGTCCTTGATTTTGAGCAACAACTCTTTTTCTGGGTCTCTTCCGAGTCAAGTGTTTTGGAATATGACGAGGATTGAAATCGCCAACAACAACTTCTCGGGTGGGATATCTGTTGGGATTACTTCAGCTAAAAATCTGATGTTTCTTGATGCCAGAAACAACATGCTTTTGGGTGAAATTCCAAGGGAATTGACTCAACTTTCACAGCTTACAGCTCTCATGCTGGATGGTAACCAACTTTCGGGTGCACTTCCATCTGAGATTATTTCGTGGCAATCACTGAACATTTTGACACTATCAGGAAACAAACTTTCTGGCCAGATTCCCACGGCTATTACTGCTCTTCCCCGCCTGGCTTACCTGGACTTGTCTCAAAACGACATATCAGGTGAAATACCTCCTCAGTTTGATAGGTTGCGGTTTGTTTTCCTCAACTTGTCCTCCAACCGGCTATCTGGGAAAATTCCTGATGAGTTCAATAACCTCGCATTTGAAAACAGTTTCTTGAACAATCCTCATCTATGTGCTTACAATCCAAACGTCCACCTTGACAACTGCTTGACCAAAACCGCGTCAGCGGCACCACAGTCGAGCAATTCGTCTTCGAAATCAGTGGCCCTGGTTCTGGCTGCCACTGCGGTTGTGTTAGCGGCAATAGCTTCCTTGGTCTACTATATGTTGAAAACGCAATGGGGCAAAAAGCACTGCGGGCATAAAAATAAGGTTGCAACGTGGAGGCTCACTTCATTCCAGAAGCTTGATCTCACGGAAATAAACTTCCTCTCGAGTTTGACAGACAATAACCTCATAGGGAGTGGAGGGTTTGGGAAAGTTTACCGGATTGCTTCAAATCGTCCAGGTGAGTATGTTGCGGTGAAGCGGATCTGGAATCGCGAGAATGTGGATGACAAGTTGGAGAAAGAGTTCCAGACTGAGGTTGAGATCCTGGGCAACATTCGCCACTCGAATATAGTGAAGCTTTTGTGCTGCTATGCAAGTGAGAATTCCAAACTTCTTGTTTATGAATACATGGAAAATCAGAGCCTGGACAAATGGCTTCATGCAGAGGAAAAAACATCGCCTCCTGGGTTGAGTTGGCCAACGAGGTTGAATATTGCCATTGGGACTGCACAAGGCCTGTGTTACATGCACCATGAATGCTCACCCCCCGTCATCCACCGAGACGTCAAATCTAGCAATATACTGTTGGACTCAGAGTTCAGAGCTAAAATAGCAGATTTTGGGCTCGCCAAGATGTTGGCAAAGCCCGGTGAACTAAACACCATGTCTGCACTAGCAGGCTCTTTTGGCTACATTCCACCAGAATATGCTTACTCAACTAAGATTAACGAGAAAGTTGATGTTTATAGCTTTGGTGTTGTGCTCTTAGAGCTTGTTACGGGAAGGAAGCCTAATATAAGCGGCGAGCGTGCATGCAGCTTAGTTGAATGGGCGTGGGAGCATTTTAATGAAGCCAAGAGCCTTACTGATGCATTCGATGAGAATGTCAAAGAACCACGTTATGCGCAAGAGATGGCTAATGTCTTCAAATTGGGCCTCCTTTGCACAAGCTCCTTGCCCTCAACCAGACCTTCCACGAAGGAGATTTTGCAAGTACTTCGGTGTTGTCATTCAGGTTCTACACGTAGAAAAATGGGAAATGAGTTTGATATCGCTCCTCTACTTGGGGACACAAGGTACGTTTGTAGTTACAAGGAGAGTAATGCTGCAACCAATAACTCATCTTGGTGA | 3057 | 0.4642 | MSKVPLFISFHFFLLFSVAVPSRVISETEQTILLTLKRELGDPPSLRSWKPSPSAPCEWAEIGCSSGGAVTKLVLSSKGITTTKSLPSTICNLKHLLELNLFNNSISGEFPTTLYECSNLRYLNLSQNYLAGAIPADVDRLKTLTFLDLSANSFSGEIPAAIGNLSELQTLYLSANNFEGTVPREIGNLLNLEFLGLAYNLKLAPWEFPLEFRKLKNLRSMYMPQCNLIGEIPEYFGDIFTNLERLDLGKNKLSGSIPRNLFSLRKLRFLYLFSNRLSGVIPSTTMQCLELIELDFAKNNLTGSIPPEFGKLKNLSTLHLYENHLVGEIPVSLSQIPSLVYFRVFSNNLSGTLPPELGLHSKLTVFEVSENQLSGGLPEHLCAGGALIGVVAFSNNFSGVLPEWIGNCPSLATVQLYNNKFSGEVPLGLWTMNNLSSLILSNNSFSGSLPSQVFWNMTRIEIANNNFSGGISVGITSAKNLMFLDARNNMLLGEIPRELTQLSQLTALMLDGNQLSGALPSEIISWQSLNILTLSGNKLSGQIPTAITALPRLAYLDLSQNDISGEIPPQFDRLRFVFLNLSSNRLSGKIPDEFNNLAFENSFLNNPHLCAYNPNVHLDNCLTKTASAAPQSSNSSSKSVALVLAATAVVLAAIASLVYYMLKTQWGKKHCGHKNKVATWRLTSFQKLDLTEINFLSSLTDNNLIGSGGFGKVYRIASNRPGEYVAVKRIWNRENVDDKLEKEFQTEVEILGNIRHSNIVKLLCCYASENSKLLVYEYMENQSLDKWLHAEEKTSPPGLSWPTRLNIAIGTAQGLCYMHHECSPPVIHRDVKSSNILLDSEFRAKIADFGLAKMLAKPGELNTMSALAGSFGYIPPEYAYSTKINEKVDVYSFGVVLLELVTGRKPNISGERACSLVEWAWEHFNEAKSLTDAFDENVKEPRYAQEMANVFKLGLLCTSSLPSTRPSTKEILQVLRCCHSGSTRRKMGNEFDIAPLLGDTRYVCSYKESNAATNNSSW* | 1019 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vra5g1001 | 1018 | SUPERFAMILY | Protein kinase-like (PK-like) | 693 | 975 | IPR011009 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 165 | 189 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 432 | 456 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 312 | 336 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 93 | 117 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 502 | 526 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 240 | 264 | IPR003591 | - | |
| Vra5g1001 | 1018 | SMART | LRR_typ_2 | 550 | 573 | IPR003591 | - | |
| Vra5g1001 | 1018 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 826 | 838 | IPR008271 | GO:0004672|GO:0006468 | |
| Vra5g1001 | 1018 | Pfam | Leucine rich repeat N-terminal domain | 29 | 65 | IPR013210 | - | |
| Vra5g1001 | 1018 | ProSitePatterns | Protein kinases ATP-binding region signature. | 705 | 728 | IPR017441 | GO:0005524 | |
| Vra5g1001 | 1018 | Gene3D | Ribonuclease Inhibitor | 25 | 205 | IPR032675 | - | |
| Vra5g1001 | 1018 | CDD | STKc_IRAK | 705 | 975 | - | - | |
| Vra5g1001 | 1018 | SUPERFAMILY | L domain-like | 291 | 599 | - | - | |
| Vra5g1001 | 1018 | SMART | serkin_6 | 699 | 975 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vra5g1001 | 1018 | PANTHER | KINASE FAMILY WITH LEUCINE-RICH REPEAT DOMAIN-CONTAINING PROTEIN | 15 | 991 | - | - | |
| Vra5g1001 | 1018 | Gene3D | Transferase(Phosphotransferase) domain 1 | 779 | 994 | - | - | |
| Vra5g1001 | 1018 | Gene3D | Phosphorylase Kinase; domain 1 | 679 | 778 | - | - | |
| Vra5g1001 | 1018 | Pfam | Protein kinase domain | 701 | 973 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vra5g1001 | 1018 | Gene3D | Ribonuclease Inhibitor | 350 | 623 | IPR032675 | - | |
| Vra5g1001 | 1018 | Gene3D | Ribonuclease Inhibitor | 206 | 349 | IPR032675 | - | |
| Vra5g1001 | 1018 | Pfam | Leucine rich repeat | 226 | 277 | IPR001611 | GO:0005515 | |
| Vra5g1001 | 1018 | PANTHER | RECEPTOR KINASE-LIKE PROTEIN XA21 | 15 | 991 | - | - | |
| Vra5g1001 | 1018 | ProSiteProfiles | Protein kinase domain profile. | 699 | 982 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vra5g1001 | 1018 | SUPERFAMILY | L domain-like | 32 | 374 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vra5g1001 | Vra-Chr5 | 16438992 | 16442346 | Dispersed/Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vra5g1001 | 18 | 997 | Receptor kinase-like Gene Family | AT5G25930 | 51.623 | 0.0 | 960 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XI-1 | Vra5g1001 | Pkinase | 2.7e-49 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vra5g1001 | K00924 | - | gmx:100782466 | 1555.81 |